Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study — Stella

Home/NSCLC/Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

View on ClinicalTrials.gov

Recruiting

Back to NSCLC trials

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang

Key details

Phase

Safety & dosing

Sponsor

Zhejiang Provincial People's Hospital

Enrollment target

~260 participants

Started

July 2024

Primary completion

July 2026

Age range

18 Years – 65 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.